Adonis raised a $40 million Series C funding round to help hospitals use AI to tackle denied and underpaid claims. Its platform automates manual revenue cycle tasks and provides real-time insights, which allows staff to focus on higher-value work. Customers include Mount Sinai Health System, Baptist Health South Florida, AdventHealth and ApolloMD. The post Adonis…
Merck has been acquiring assets that could help make up for the coming revenue decline as its top product, the cancer drug Keytruda, drops off the patent cliff. Terns Pharmaceuticals’ lead product candidate, in development for treating a type of leukemia, could offer dosing and efficacy advantages over the Novartis drug Scemblix. The post Merck’s…
Residents embrace AI for everything from clinical decisions to emotional support. Health systems need to meet them where they are. The post A New Opportunity to Reduce Resident Burnout: Young Doctors Are AI Natives appeared first on MedCity News.
[Sponsored] Luxury rehab means more than high-thread-count sheets and a view. The post Key Amenity Categories in Luxury Rehabs, According to The Sanctuary at Sedona appeared first on MedCity News.
Our biggest healthcare problems aren’t only cost or access, but the breakdown in how diagnoses are made, especially for women. Digital health’s new era of AI and real-time data is the most promising solution I’ve seen to fix this, but for these tools to work for women, they must be built on data that actually…
[Sponsored] By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients. The post Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork appeared first on MedCity News.
At Wayne General Hospital in rural Mississippi, clinicians are using Eko Health’s AI-powered digital stethoscope to detect heart conditions earlier in patients with limited access to specialists. The post How A Small Rural Hospital Is Using AI to Catch Heart Disease Sooner appeared first on MedCity News.
Rising healthcare costs are a key focus for AHIP, whose CEO says the group is pushing reforms to boost competition and reduce administrative burden. The post AHIP CEO: “We Are Laser-Focused on Affordability” appeared first on MedCity News.
Gilead Sciences is acquiring Ouro Medicines, a startup developing T cell engagers for a range of autoimmune diseases. Separately, Gilead is negotiating a deal with Galapagos to share in the development and potential commercialization of the Ouro drug. The post Gilead Sciences Gains an Opportunity for Immune System Reset With $1.7B Ouro Acquisition appeared first…
The specialty access and capacity crisis demands more than incremental fixes. It requires expanding virtual access and fundamentally rethinking how specialty care can be delivered. The post Virtual Specialty Care Has Time. Will We Use It Wisely? appeared first on MedCity News.